Retatrutide Spec.(10vials/box)

Retatrutide is a weight-loss medication that’s in development. It works by acting like three gut hormones that help balance appetite and metabolism.

Phase 2 clinical trials found that people using retatrutide lost an average of 24% of their starting body weight. A phase 3 trial will help confirm how well retatrutide works for weight loss.

Retatrutide’s phase 3 trial should finish in early 2026. It’s possible that the FDA could approve it in 2027.

Weight-loss injections have exploded in popularity in recent years. Medications like Wegovy (semaglutide) and Zepbound (tirzepatide) have been in the spotlight. Considering how well they work, it’s easy to see why.

But there are several other weight-loss medications that scientists are researching. And early studies suggest that some products in development might work better than those already on the market. Retatrutide is one medication in the pipeline that fits this description.

How does retatrutide work for weight loss? And when might it be FDA approved? Let’s discuss seven things you should know about retatrutide.

1. Retatrutide works differently from other weight-loss medications

Similar to Wegovy and Zepbound, retatrutide acts like natural hormones found in the body. But instead of acting like one or two hormones, retatrutide acts like three:

Glucose-dependent insulinotropic polypeptide (GIP)

Glucagon-like peptide-1 (GLP-1)

Glucagon

GIP and GLP-1 tell your pancreas to release insulin after eating. They also lower the amount of new sugar (glucose) that your liver makes. What’s more, GIP and GLP-1 slow digestion to help you feel fuller. And they target areas of your brain that regulate appetite and influence food cravings.